skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

734 Total results for product and free and sample content found

Pink Sheet

Getting Worse Not Better: UK Report On Access To Cancer Drugs

05 Dec 2018

A UK report on patient access to cancer drugs suggests that the European Medicines Agency could learn from the US Food and Drug Administration and best practice elsewhere in the world when it comes to taking a faster, more flexible approach to assessing evidence.

Topic Cancer

In Vivo

Medical Aesthetics: A Untapped Pharma Market With Incoming Competition

By Mandy Jackson 05 Dec 2018

Medical aesthetics is a unique biopharmaceutical niche that may scare off companies due to the consumer marketing and doctor relationship-building skills needed to compete in this market, but the potential for growth keeps major players engaged and searching for new technology.

Topic BioPharmaceutical

Medtech Insight

EU Regulatory Roundup November 2018

By Amanda Maxwell 05 Dec 2018

The medtech sector was already quite overwhelmed with the new EU regulations and Brexit uncertainties. Now add into the mix the impact of the global journalistic Implant Files investigation.

Topic Brexit Medtech

Medtech Insight

FDA Device Panel Delivers Thumbs Up For Breakthrough Heart-Failure Device

By Elizabeth Orr 05 Dec 2018

A US FDA panel overwhelmingly supported a heart-failure device designed to use cardiac contractility modulation to improve heart function. The Optimizer Smart system from Impulse Dynamics is apparently the first in FDA’s Breakthrough Devices program to go before an advisory panel.

Topic FDA

Scrip

No, It's Not Just Out-Of-Pocket Costs That Are A Problem, John Arnold Tells Pharma

By Jessica Merrill 05 Dec 2018

The billionaire philanthropist and industry agitator took the stage at the Forbes Healthcare Summit to discuss why his foundation is focused on fixing drug pricing and supporting organizations like ICER and Patients for Affordable Drugs.

Topic Drug approval Drug development landscape Drug review

Scrip

Imbruvica Replaces Chemo, Darzalex Boosts Standard Of Care In Front-Line CLL, Myeloma

By Mandy Jackson 05 Dec 2018

Late-breaker presentations at ASH showed that replacing chemotherapy agents with Imbruvica in CLL, and adding Darzalex to Revlimid and dexamethasone in multiple myeloma, is more effective than current standards of care in certain front-line settings.

Topic Cancer Drug approval

Scrip

AI-Driven Drug Development Seen Blossoming In Korea As Govt Lends Support

By Jung Won Shin 05 Dec 2018

Application of artificial intelligence to new drug development in South Korea, which has been lagging in this area, is poised to accelerate as the country moves to support and encourage the technology.

Topic Drug development landscape Drug review

Scrip

Mens Health Drug Developments in Prostate Cancer

06 Nov 2018

November is Men’s Health Awareness Month, and Informa Pharma Intelligence is providing essential insights into drug developments for prostate cancer. Download now for free the "Men's Health: Drug Developments in Prostate Cancer Article Pack", brought to you by Scrip and Pink Sheet.

Topic Drug development landscape

Medtech Insight

Commissioner Says EU MDR/IVDR Implementation 'On Track,' But Fails To Convince Parliament

By Amanda Maxwell 31 Oct 2018

Elżbieta Bieńkowska, a European Commissioner,  is "realistic and confident" when it comes to the implementation of the new EU medtech regulations. She says everything is going to plan. But that is not what members of the European Parliament are hearing.

Topic Medtech

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: